BioHarvest Sciences (BHST) to Release Quarterly Earnings on Thursday

BioHarvest Sciences (NASDAQ:BHST) is expected to be announcing its Q4 2025 results before the market opens on Thursday, April 23rd. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $9.2390 million for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, March 31, 2026 at 4:30 PM ET.

BioHarvest Sciences Stock Up 1.6%

BioHarvest Sciences stock opened at $4.42 on Tuesday. The firm has a market cap of $86.72 million, a price-to-earnings ratio of -7.25 and a beta of 1.16. The stock has a fifty day simple moving average of $4.42 and a two-hundred day simple moving average of $6.11. BioHarvest Sciences has a 12 month low of $4.10 and a 12 month high of $12.80. The company has a current ratio of 3.97, a quick ratio of 3.38 and a debt-to-equity ratio of 0.10.

Wall Street Analysts Forecast Growth

A number of analysts have commented on BHST shares. Roth Mkm started coverage on BioHarvest Sciences in a report on Thursday, February 19th. They issued a “buy” rating and a $10.00 target price for the company. Weiss Ratings reissued a “sell (d-)” rating on shares of BioHarvest Sciences in a report on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $12.50.

Institutional Trading of BioHarvest Sciences

Several large investors have recently modified their holdings of the company. Alyeska Investment Group L.P. bought a new stake in shares of BioHarvest Sciences in the fourth quarter worth $3,929,000. Evercore Wealth Management LLC bought a new stake in shares of BioHarvest Sciences in the fourth quarter worth $724,000. Osaic Holdings Inc. grew its holdings in shares of BioHarvest Sciences by 5,510.4% in the fourth quarter. Osaic Holdings Inc. now owns 35,233 shares of the company’s stock worth $183,000 after acquiring an additional 34,605 shares during the period. XTX Topco Ltd bought a new stake in shares of BioHarvest Sciences in the fourth quarter worth $173,000. Finally, Jane Street Group LLC purchased a new position in BioHarvest Sciences during the fourth quarter valued at $145,000.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.

The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets.